Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
2012/04/06 by Helena Bjermo, David Iggman, Joel Kullberg +13 · 1 voice · 32 citations
Nursing · Medicine · Agricultural and Biological Sciences · #Fatty Acid Research and Health #Adipokines, Inflammation, and Metabolic Diseases #Food Chemistry and Fat Analysis
paper · pdf · doi:10.3945/ajcn.111.030114
Cited by
- Non-pharmacological treatment of MASLD
- Ultra-processed Plant Foods: Are They Worse than their Unprocessed Animal-Based Counterparts?
- Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes
- Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
- Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans
- BMI modifies the effect of dietary fat on atherogenic lipids: a randomized clinical trial
- Concerns about the health effects of industrially produced seed oils are without scientific foundation: a scoping narrative review of the clinical and observational evidence
- Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets. [europepmc]
- Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. [europepmc]
- Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. [europepmc]
- The influence of dietary fat on liver fat accumulation. [europepmc]
- Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance. [europepmc]
- Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review. [europepmc]
- The Deep Correlation between Energy Metabolism and Reproduction: A View on the Effects of Nutrition for Women Fertility. [europepmc]
- Effects of Saturated Fat, Polyunsaturated Fat, Monounsaturated Fat, and Carbohydrate on Glucose-Insulin Homeostasis: A Systematic Review and Meta-analysis of Randomised Controlled Feeding Trials. [europepmc]
- Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. [europepmc]
- Influence of dietary macronutrients on liver fat accumulation and metabolism. [europepmc]
- Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. [europepmc]
- Links between Dietary Protein Sources, the Gut Microbiota, and Obesity. [europepmc]
- Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars. [europepmc]
- Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study. [europepmc]
- ω-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps. [europepmc]
- Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver. [europepmc]
- Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease. [europepmc]
- Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality. [europepmc]
- Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial. [europepmc]
- Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid. [europepmc]
- Naturally Occurring PCSK9 Inhibitors. [europepmc]
- Dietary Options for Rodents in the Study of Obesity. [europepmc]
- Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial. [europepmc]
- Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development. [europepmc]
- Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. [europepmc]
Discussions